A Study of an Implantable Miniature Telescope in Patients With With End-Stage AMD

VisionCare, Inc.18 enrolled

Overview

Evaluation of pre and post-implantation management of patients with end-stage age-related macular degeneration (AMD) who have been implanted with the implantable telescope (IMT) under CE Mark indicated use. This study is designed to evaluate in particular the optimal parameters for patient selection for use of this device in routine clinical practice.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

End Stage Macular Degeneration

Interventions

Telescope prosthesisDEVICE

Monocular implantation of the telescope prosthesis after cataract extraction

Eligibility

Sex: ALLMin age: 55 Years

Medical Language ↔ Plain English

Inclusion Criteria: CE Mark approved indication of use which includes * At least 55 years of age * Bilateral visual impairment due to geographic atrophy or disciform scars * Evidence of cataract Exclusion Criteria: * Active CNV (or 'wet' AMD) * Prior cataract or refractive surgery in the study eye

Locations (4)

Frimley Park Hospital NHS Trust

Frimley, Surrey, United Kingdom

Royal Hospitals, Belfast Health & Social Care Trust

Belfast, United Kingdom

Moorfields Eye Hospital NHS Trust

London, United Kingdom

King's College Hospital NHS Trust

London, United Kingdom

Outcomes

Primary Outcomes

Best-Corrected Visual Acuity

Time frame: 1 year

Secondary Outcomes

Quality of Life

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.